Author | Monica Ventriglia, MD


Uracil/Tegafur Plus Oral Calcium Folinate in Advanced Breast Cancer

July 01, 1999

ByEduardo Richardet, MD, PhD|Cecilia Pedraza, MD|Elizabeth Mickiewicz, MD|Guillermo Lerzo, MD|Federico Coppola, MD|Alicia Elli, MD|Graciela Uranga, MD|Silvia Jovtis, MD|Mario Bruno, MD|Monica Ventriglia, MD|Maria Andrea Cuevas, MD|Ana Maria Alvarez, MD|Luis Alberto Suarez, MD|Luis Fein, MD

Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may